Diogo Vila-Viçosa

Diogo Vila-Viçosa

Auto-generated profile, based on publicly available information

Diogo Vila-Viçosa

Centro de Química e Bioquímica, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade de Lisboa , 1749-016 Lisboa, Portugal

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2020 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
PRPedro B. P. S. Reis
Pedro B. P. S. Reis
DVDiogo Vila-Viçosa
Diogo Vila-Viçosa
WRWalter Rocchia
Walter Rocchia
Miguel MachuqueiroMiguel Machuqueiro
Miguel Machuqueiro

16 February 2016 in Journal of Chemical Theory and Computation
Verified
Journal Article
Closed access
VTVitor H. Teixeira
Vitor H. Teixeira
DVDiogo Vila-Viçosa
Diogo Vila-Viçosa
PRPedro Reis
Pedro Reis
Miguel MachuqueiroMiguel Machuqueiro
Miguel Machuqueiro


9 March 2021 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
RNRafael Nunes
Rafael Nunes
DVDiogo Vila-Viçosa
Diogo Vila-Viçosa
Paulo J. CostaPaulo J. Costa
Paulo J. Costa

21 May 2019 in Expert Opinion on Drug Discovery
Verified
Journal Article
Closed access
Paulo J. CostaPaulo J. Costa
Paulo J. Costa
RNRafael Nunes
Rafael Nunes
DVDiogo Vila-Viçosa
Diogo Vila-Viçosa
Introduction: Halogens have a prominent role in drug design. Often used as a mean to improve ADME properties, they are also becoming a tool in protein–ligand recognition given their ability to form a non-covalent interaction, termed halogen bond, where halogens act as electrophilic species interacting with electron-rich partners. Rational drug design of halogen-bonding lead molecules requires an accurate description of halocarbon-protein complexes by computational tools though not all methods are able to tackle this non-covalent interaction. Areas covered: The authors present a review of computational methodologies that can be used to properly describe halogen bonds in the context of protein–ligand complexes, providing also insights on how these methods can be used in the context of computer-aided drug design. Expert opinion: Although in the last few years many computational tools, ranging from fast screening methods to the more expensive QM calculations, have been developed to tackle the halogen bonding phenomenon, they are not yet standard in the literature. This will eventually change as official software distributions are including support for halogen bonding in their methods. Tackling desolvation of halogenated species seems to be a good strategy to improve the accuracy of computational methods, that will be more commonly used prior to laboratory work in the future.

24 October 2018 in Journal of Chemical Theory and Computation
Verified
Journal Article
Closed access
TSTomás F. D. Silva
Tomás F. D. Silva
DVDiogo Vila-Viçosa
Diogo Vila-Viçosa
PRPedro Reis
Pedro Reis
BVBruno L. Victor
Bruno L. Victor
MDMatthias Diem
Matthias Diem
Miguel MachuqueiroMiguel Machuqueiro
Miguel Machuqueiro